Has anyone on the forum been on a clinical trial for this new form of treatment and is it going to become more widely available

Overview | Foslevodopa–foscarbidopa for treating advanced Parkinson’s with motor symptoms | Guidance | NICE

New treatment for Parkinson’s approved by NICE (The National Institute for Health and Care Excellence) | Parkinson’s UK (

Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson’s disease: a randomised, double-blind, active-controlled, phase 3 trial - The Lancet Neurology